Similar to PD-L1, CD276 prevents the surveillance of tumor cells by cytotoxic T and NK-cells [65] and its expression on BC cells has been reported to associate with poor prognosis, enlarged tumor size, lymph node migration and cancer recurrence [66, 67]. This evidence concerns the gene CD276 and breast cancer.